[1] |
FENG Xinying, WANG Bing, LIU Peifeng.
Innovations and challenges in intraperitoneal chemotherapy for peritoneal metastatic carcinoma
[J]. China Oncology, 2024, 34(9): 827-837.
|
[2] |
CAO Fei, YU Wenhao, TANG Xiaonan, MA Zidong, CHANG Tingmin, GONG Yabin, LIAO Mingjuan, KANG Xiaohong.
Mechanism of LINC01410 promoting proliferation and migration in esophageal squamous cell carcinoma
[J]. China Oncology, 2024, 34(8): 753-762.
|
[3] |
CAO Xiaoshan, YANG Beibei, CONG Binbin, LIU Hong.
The progress of treatment for brain metastases of triple-negative breast cancer
[J]. China Oncology, 2024, 34(8): 777-784.
|
[4] |
HUANG Sijie, KANG Xun, LI Wenbin.
Clinical research progress of intrathecal therapy in the treatment of leptomeningeal metastasis
[J]. China Oncology, 2024, 34(7): 695-701.
|
[5] |
XU Yonghu, XU Dazhi.
Progress and prospects of gastric cancer treatment in the 21st century
[J]. China Oncology, 2024, 34(3): 239-249.
|
[6] |
CHEN Yifan, LI Ting, WANG Biyun.
Research progress of CCR8 in tumor immunotherapy
[J]. China Oncology, 2024, 34(3): 299-305.
|
[7] |
JIN Yizi, LIN Mingxi, ZENG Cheng, GUO Qing, ZHANG Jian.
Research advances in estrogen receptor low positive early breast cancer
[J]. China Oncology, 2024, 34(10): 972-978.
|
[8] |
LIU Xuerou, YANG Yumei, ZHAO Qian, RONG Xiangyu, LIU Wei, ZHENG Ruijie, PANG Jinlong, LI Xian, LI Shanshan.
Research progress on the role of glutamine metabolism-related proteins in tumor metastasis
[J]. China Oncology, 2024, 34(1): 97-103.
|
[9] |
KANG Yinnan, CHEN Shun, XIE Youcheng, ZHENG Ying, HE Yujing, LI Chuyi, YU Xiaohui.
Application and research progress of antibody drug conjugates in HER2 positive advanced gastric cancer
[J]. China Oncology, 2023, 33(8): 790-800.
|
[10] |
YE Junling, ZHENG Xiaoying, GUO Xinjian, CHEN Ruihui, YANG Liu, GOU Xiaodan, JIANG Hanmei.
A study on mechanism of lncRNA-mediated SNHG5/miR-26a-5p/MTDH signal axis promoting metastasis of colorectal cancer
[J]. China Oncology, 2023, 33(7): 673-685.
|
[11] |
WU Jing, ZHOU Juan, SU Chunxia.
Advances in fatty acid metabolism reprogramming of lung cancer
[J]. China Oncology, 2023, 33(5): 517-526.
|
[12] |
JIANG Jinling, ZHOU Chenfei, WANG Chao, ZHAO Liqin, WU Junwei, ZHANG Jun.
Advanced progress in research and diagnosis of gastric cancer in 2022
[J]. China Oncology, 2023, 33(4): 303-314.
|
[13] |
TIAN Xi, XU Wenhao, ZHU Shuxuan, AIHETAIMUJIANG•Anwaier, SU Jiaqi, YE Shiqi, QU Yuanyuan, SHI Guohai, ZHANG Hailiang, YE Dingwei.
Advances in the research, diagnosis and treatment of renal cell carcinoma in 2022
[J]. China Oncology, 2023, 33(3): 191-200.
|
[14] |
SU Chunxia, ZHOU Caicun.
Important clinical research progress in lung cancer in 2022
[J]. China Oncology, 2023, 33(3): 218-227.
|
[15] |
CAO Xiaoshan, CONG Binbin.
The research progress of endocrine therapy combined with targeted therapy for triple-positive breast cancer
[J]. China Oncology, 2023, 33(3): 288-292.
|